Article
Oncology
Javier A. Menendez, Adriana Papadimitropoulou, Travis Vander Steen, Elisabet Cuyas, Bharvi P. Oza-Gajera, Sara Verdura, Ingrid Espinoza, Luciano Vellon, Inderjit Mehmi, Ruth Lupu
Summary: The study highlights the critical role of fatty acid synthase (FASN) in HER2-driven tamoxifen resistance and suggests that FASN inhibition could be a novel therapeutic approach to restore tamoxifen sensitivity in endocrine-resistant breast cancer.urther research using next-generation FASN inhibitors may be therapeutically relevant in countering resistance to tamoxifen in FASN-overexpressing ER+/HER2+ breast carcinomas.
Article
Biochemistry & Molecular Biology
Dina Hany, Marloes Zoetemelk, Kaushik Bhattacharya, Patrycja Nowak-Sliwinska, Didier Picard
Summary: Breast cancer is a persistent threat to women worldwide, and current monotherapies often face issues of drug resistance and toxicity. By mining data and constructing a network, we identified two multidrug combinations with high therapeutic relevance for ER alpha positive/HER2-/PI3K alpha mutant subtype of breast cancer.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2023)
Article
Oncology
Lin Yang, Travis Vander Steen, Ingrid Espinoza, Elisabet Cuyas, Sara Verdura, Javier A. Menendez, Ruth Lupu
Summary: This study reveals the nuclear translocation mechanism of HRG in breast cancer and suggests that nuclear HRG has different functions and effects from extracellular HRG, providing a new paradigm for the functional and therapeutic research of nuclear HRG in breast cancer.
AMERICAN JOURNAL OF CANCER RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Alok Mishra, Anshuman Srivastava, Ankit Pateriya, Manendra Singh Tomar, Anand Kumar Mishra, Ashutosh Shrivastava
Summary: Breast cancer is the most common cancer among females, and endocrine therapy for ER-positive breast cancer can result in acquired resistance. The metabolic state of cancer cells plays a crucial role in their susceptibility to chemotherapeutic drugs, and understanding metabolic pathway alterations in TAMR cancer may offer potential therapeutic strategies.
CHEMICO-BIOLOGICAL INTERACTIONS
(2021)
Article
Biochemistry & Molecular Biology
Xiaoli Liang, Yang Zhao, Zeng Fang, Nan Shao, Duanyang Zhai, Mengmeng Zhang, Liang Yu, Yawei Shi
Summary: The study revealed that DLGAP1-AS2 is significantly upregulated in breast cancer, promoting ER signaling and causing tamoxifen resistance. Downregulating DLGAP1-AS2 could potentially overcome tamoxifen resistance in breast cancer.
MOLECULAR BIOLOGY REPORTS
(2022)
Article
Oncology
Ho Tsoi, Ellen P. S. Man, Ka Man Chau, Ui-Soon Khoo
Summary: This study identifies the molecular mechanisms through which BQ323636.1 enhances IL-6/STAT3 signaling, promoting tamoxifen resistance in ER+ breast cancer. High IL-6R expression is significantly associated with tamoxifen resistance, and targeting IL-6R with Tocilizumab can reverse this resistance. Analysis of clinical samples confirmed the correlation between IL-6R expression, BQ expression, and tamoxifen resistance in primary breast cancer. High IL-6R expression is linked to poorer survival outcomes in ER+ breast cancer.
Article
Oncology
Derek Dustin, Guowei Gu, Amanda R. Beyer, Sarah K. Herzog, David G. Edwards, Hangqing Lin, Thomas L. Gonzalez, Sandra L. Grimm, Cristian Coarfa, Doug W. Chan, Beom-Jun Kim, O. Jean-Paul De La, Matthew J. Ellis, Dan Liu, Shunqiang Li, Alana L. Welm, Suzanne A. W. Fuqua
Summary: This study identified hyperactivation of RON in ESR1 mutant cells and its association with acquired palbociclib-resistant models. The interaction between RON and IGF-1R was demonstrated, and combination therapy of endocrine therapy with a RON inhibitor effectively decreased organoid growth in ESR1 mutant models. Additionally, the combination therapy also reduced metastasis in an ESR1 Y537S mutant PDX model, suggesting RON/PI3K pathway inhibition as a potential treatment strategy for ESR1 mutant and PalbR MBC patients.
BRITISH JOURNAL OF CANCER
(2021)
Review
Oncology
Santiago Duro-Sanchez, Macarena Roman Alonso, Joaquin Arribas
Summary: A variety of treatments are available for HER2-positive breast cancer, but resistance to these therapies is common and associated with poor prognosis. Immunotherapeutic approaches are being explored to eradicate tumor cells and prevent relapse and progression. This review discusses the different immunotherapeutic strategies being tested and their potential benefits for HER2-positive breast cancer.
Article
Biochemical Research Methods
Seunghyun Wang, Doheon Lee
Summary: In this study, two prognostic subgroups (BPS-LumA and WPS-LumA) of luminal-A breast cancer were identified using deep autoencoders and gene expressions. The prognostic difference between the two subgroups was validated using external datasets. The study also found that latent features were superior to gene expression profiles in discovering the prognostic subgroups.
PLOS COMPUTATIONAL BIOLOGY
(2023)
Article
Multidisciplinary Sciences
Ho Hyun Ryu, Sei Hyun Ahn, Seon Ok Kim, Jeong Eun Kim, Ji Sun Kim, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Hee Jung Shin, Hak Hee Kim, Gyung Yub Gong, Hee Jeong Kim
Summary: The metabolic profiles of patients undergoing neoadjuvant chemotherapy (NCT) and neoadjuvant endocrine therapy (NET) were compared 3 years after treatment, showing significant differences in BMI, serum glucose, and total cholesterol between the two groups. NCT was found to worsen metabolic profiles during treatment, but these effects normalized over time, while NET had minimal metabolic effects. The neutrophil-to-lymphocyte ratio (NLR) increased after NCT but decreased after NET.
SCIENTIFIC REPORTS
(2021)
Article
Pharmacology & Pharmacy
Bo-Wei Wang, Chih-Hao Huang, Liang-Chih Liu, Fang-Ju Cheng, Ya-Ling Wei, Yueh-Ming Lin, Yu-Fei Wang, Ching-Ting Wei, Yeh Chen, Yun-Ju Chen, Wei-Chien Huang
Summary: Pim1 kinase is closely associated with HER2 expression and its inhibitor can effectively downregulate HER2 expression and overcome resistance to HER2 tyrosine kinase inhibitor in breast cancer cells.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Xiaoxiao Liu, Xing Zhang, Zhiying Shao, Xiaorong Zhong, Xin Ding, Liang Wu, Jie Chen, Ping He, Yan Cheng, Kunrui Zhu, Dan Zheng, Jing Jing, Ting Luo
Summary: This study reports the efficacy and mechanism of the combination treatment of pyrotinib and chrysin in HER2-positive breast cancer. The results showed that the combination treatment enhanced autophagy and inhibited tumor growth through the miR-16-5p/ZBTB16/G6PD axis.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2023)
Article
Medicine, Research & Experimental
Sewon Hwang, Soojun Park, Jee Hyun Kim, Sang-Beom Bang, Hyeon-Ji Kim, Na-Lee Ka, Yoonae Ko, Seung-Su Kim, Ga Young Lim, Seunghee Lee, Young Kee Shin, So Yeon Park, Sanghee Kim, Mi-Ock Lee
Summary: This study aimed to identify lipid metabolic perturbations in tamoxifen-resistant breast cancer (BC) and investigate the role of HMGCS2 in BC growth. Comprehensive metabolomics and transcriptomics analysis were conducted. The upregulation of HMGCS2 was verified in tamoxifen-resistant BC cells and clinical samples. A HMGCS2 inhibitor was discovered and its effect on tumor growth was studied.
Article
Oncology
Chewei Anderson Chang, Jayu Jen, Shaowen Jiang, Azin Sayad, Arvind Singh Mer, Kevin R. Brown, Allison M. L. Nixon, Avantika Dhabaria, Kwan Ho Tang, David Venet, Christos Sotiriou, Jiehui Deng, Kwok-Kin Wong, Sylvia Adams, Peter Meyn, Adriana Heguy, Jane A. Skok, Aristotelis Tsirigos, Beatrix Ueberheide, Jason Moffat, Abhyudai Singh, Benjamin Haibe-Kains, Alireza Khodadadi-Jamayran, Benjamin G. Neel
Summary: Resistance to targeted therapies in HER2-positive breast cancer is often attributed to the presence of drug-tolerant persisters (DTPs). This study reveals that HER2 TKI treatment leads to the emergence of DTPs with different transcriptomes, and these DTPs are originated from pre-DTP cells that cycle stochastically. The findings provide insights into the ontogeny of DTPs and potential vulnerabilities for therapeutic targeting.
Article
Biochemistry & Molecular Biology
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
Summary: This study uncovered the role of CMTM6 in trastuzumab-resistant HER2+ breast cancer. High expression of CMTM6 was associated with worse survival and affected the stability of HER2 protein. These findings suggest CMTM6 as a potential prognostic marker and therapeutic target for overcoming trastuzumab resistance.
Article
Health Care Sciences & Services
Ali Karamoozian, Mohammad Reza Baneshi, Abbas Bahrampour
Summary: This study proposed two models using continuous gamma distribution and discrete hyper-Poisson distribution as frailty random variables, with Weibull distribution and generalized modified Weibull distribution as baseline distributions. Through simulation and analysis of gastric cancer patient data, it was found that the model with modified Weibull and hyper-Poisson distributions fits better for practical studies compared to the model with Weibull and Gamma distributions.
STATISTICAL METHODS IN MEDICAL RESEARCH
(2021)
Article
Pathology
Sara S. F. Al-Badran, Lauren Grant, Maejoy Campo, Jitwadee Inthagard, Kathryn Pennel, Jean Quinn, Prakash Konanahalli, Liam Hayman, Paul G. Horgan, Donald C. McMillan, Campbell S. D. Roxburgh, Antonia Roseweir, James H. Park, Joanne Edwards
Summary: The study indicates that high expression of LAG-3 and PD-1 is associated with poor prognosis in patients with colorectal cancer, while high expression of TIM-3, LAG-3, and PD-1 in stromal immune cells is related to improved prognosis. Additionally, immune cell LAG-3 is independently associated with survival, and a Combined Immune Checkpoint Stromal Score (CICSS) combining scores on stromal immune cells is associated with patient survival.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH
(2021)
Review
Oncology
Amna Matly, Jean A. Quinn, Donald C. McMillan, James H. Park, Joanne Edwards
Summary: The meta-analysis concluded that high nuclear expression of 8-catenin is associated with poor prognosis in terms of disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) for colorectal cancer (CRC) patients, while low membranous expression of 8-catenin is related to poor OS. Further validation with larger tissue cohorts and patient data is needed to confirm these findings.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Andrea Lampis, Jens C. Hahne, Pierluigi Gasparini, Luciano Cascione, Somaieh Hedayat, Georgios Vlachogiannis, Claudio Murgia, Elisa Fontana, Joanne Edwards, Paul G. Horgan, Luigi Terracciano, Owen J. Sansom, Carlos D. Martins, Gabriela Kramer-Marek, Carlo M. Croce, Chiara Braconi, Matteo Fassan, Nicola Valeri
Summary: JAM-A downregulation is common in CRC and correlates with poor prognosis; Dysregulation of JAM-A promotes invasiveness and metastasis in CRC by activating multiple oncogenic pathways.
CELL DEATH AND DIFFERENTIATION
(2021)
Review
Oncology
Mark S. Johnstone, Gerard Lynch, James Park, Stephen McSorley, Joanne Edwards
Summary: Studies have shown that various gene mutations and protein expression levels are associated with the risk of metachronous polyps, indicating the need for further research to determine more accurate risk assessment.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
(2021)
Article
Gastroenterology & Hepatology
David Mansouri, Stephen T. McSorley, James H. Park, Clare Orange, Paul G. Horgan, Donald C. McMillan, Joanne Edwards
Summary: This study found a significant increase in CD3+ and CD8+ cell infiltration in high-grade dysplastic colonic adenomas compared to low-grade dysplastic adenomas, which may be useful for prognostic stratification and treatment.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
(2021)
Article
Statistics & Probability
Sara Javadi, Abbas Bahrampour, Mohammad Mehdi Saber, Behshid Garrusi, Mohammad Reza Baneshi
Summary: The study evaluated whether recursive partitioning creates appropriate variability between imputations and unbiased parameter estimates, and determined that the MICE-Interaction method is more efficient in preserving interaction effects compared to other methods.
JOURNAL OF PROBABILITY AND STATISTICS
(2021)
Review
Medicine, Research & Experimental
Phimmada Hatthakarnkul, Jean A. Quinn, Aula Ammar, Gerard Lynch, Hester Van Wyk, Donald C. McMillan, Chanitra Thuwajit, Joanne Edwards
Summary: Colorectal cancer is the third most common cancer worldwide. Poor survival and disease metastasis are associated with the development of tumor metastasis in CRC patients, making it important to study potential biomarkers for predicting outcomes. Tumor budding is an independent prognostic marker for poor survival and disease metastasis, and it has been suggested to be included in routine clinicopathological factors for risk assessment. However, there is currently no clear evidence regarding the underlying molecular mechanism driving this phenotype, or the relationship between tumor budding and the tumor microenvironment.
Article
Mathematical & Computational Biology
Mehran Nakhaeizadeh, Maryam Chegeni, Masoumeh Adhami, Hamid Sharifi, Milad Ahmadi Gohari, Abedin Iranpour, Mahdieh Azizian, Mashaallah Mashinchi, Mohammad Reza Baneshi, Mohammad Karamouzian, Ali Akbar Haghdoost, Yunes Jahani
Summary: This study aims to predict COVID-19-related deaths, hospitalization, and infections in Kerman, Iran under different scenarios, and assess the impact of new variants and vaccination. The findings emphasize the importance of improving vaccination and interventions to prevent more cases, hospitalizations, and deaths.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
(2022)
Article
Cell Biology
Suad A. K. Shamis, Jean Quinn, Elizabeth E. A. Mallon, Joanne Edwards, Donald C. McMillan
Summary: The prognostic significance of hypoxia markers in estrogen receptor-positive breast cancer patients was investigated. The expression of these markers was associated with clinicopathological parameters and disease-free survival.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
(2022)
Article
Health Care Sciences & Services
Azam Rastegari, Mohammad Reza Baneshi, Ahmad Hajebi, Ali Akbar Haghdoost, Hamid Sharifi, Alireza Noroozi, Mohammad Karamouzian, Mostafa Shokoohi, Ali Mirzazadeh, Saiedeh Haji Maghsoudi, Toktam Khojasteh Bojnourdi, Naser Nasiri
Summary: Using the indirect Network Scale-Up (NSU) method, this study estimated the population size of illicit drug and alcohol users in Iran. The results revealed heterogeneity in illicit drug use among different age groups, genders, and provinces. Specific interventions targeting different subgroups are needed.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT
(2023)
Article
Biochemistry & Molecular Biology
Vasudha Tandon, Rita Moreno, Kira Allmeroth, Jean Quinn, Sandra E. Wiley, Lynden G. Nicely, Martin S. Denzel, Joanne Edwards, Laureano de la Vega, Sourav Banerjee
Summary: Preserving proteostasis is a crucial survival mechanism for cancer, and targeting the kinase DYRK2 and its substrate HSF1 can induce apoptosis faster than individual targeting. This study suggests that cotargeting DYRK2 and HSF1 could be a promising strategy in suppressing cancer.
BIOSCIENCE REPORTS
(2023)
Article
Oncology
P. G. Alexander, H. C. van Wyk, K. A. F. Pennel, J. Hay, D. C. McMillan, P. G. Horgan, C. S. D. Roxburgh, J. Edwards, J. H. Park
Summary: The Glasgow Microenvironment Score (GMS) is associated with the location of recurrence in colorectal cancer. Higher GMS categories (GMS 1 and 2) are associated with an increased risk of local and distant recurrence.
BRITISH JOURNAL OF CANCER
(2023)
Article
Health Care Sciences & Services
Annette Dobson, Paul McElwee, Mohammad Reza Baneshi, James Eynstone-Hinkins, Lauren Moran, Michael Waller
Summary: This study proposes a new method for calculating the percentages of deaths attributed to different causes, taking into account the patterns of associations among causes of death. Compared to traditional methods, this new method provides a more accurate representation of the impact of multimorbidity in the aging population.
BMC MEDICAL RESEARCH METHODOLOGY
(2023)
Article
Public, Environmental & Occupational Health
Mohammad Reza Baneshi, James Eynstone-Hinkins, Paul McElwee, Gita D. Mishra, Lauren Moran, Michael Waller, Annette Dobson
Summary: The prevalence of multimorbidity increases with age and is higher among women than men. The analysis of death records in Australia reveals different patterns of multimorbidity associated with demographic characteristics.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
(2023)